{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:21:53Z","timestamp":1790108513310,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["0073\/DIA\/2019\/48"],"award-info":[{"award-number":["0073\/DIA\/2019\/48"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05485-9","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T02:24:14Z","timestamp":1739154254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of six novel biomarkers for predicting recurrence of non-muscle invasive bladder cancer after endoscopic resection\u2013 a prospective observational study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9578-0836","authenticated-orcid":false,"given":"Klaudia","family":"Bardowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-2283","authenticated-orcid":false,"given":"Wojciech","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-6309","authenticated-orcid":false,"given":"Anna","family":"Ko\u0142odziej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-438X","authenticated-orcid":false,"given":"Katarzyna","family":"Ko\u015bcielska-Kasprzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7720-7163","authenticated-orcid":false,"given":"Dorota","family":"Bartoszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-3131","authenticated-orcid":false,"given":"Marcelina","family":"\u017babi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-4450","authenticated-orcid":false,"given":"Joanna","family":"Chorbi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Kubacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2548-3008","authenticated-orcid":false,"given":"Tomasz","family":"Kr\u00f3licki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-2409","authenticated-orcid":false,"given":"Magdalena","family":"Krajewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1360-0422","authenticated-orcid":false,"given":"Tomasz","family":"Szyde\u0142ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2400-9328","authenticated-orcid":false,"given":"Dorota","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"5485_CR1","doi-asserted-by":"publisher","unstructured":"Deng S, Meng F, Wang L, Yang Z, Xuan L, Xuan Z, Wang J (2022) Global Research Trends in Non-muscle invasive bladder Cancer: bibliometric and visualized analysis. Front Oncol 12. https:\/\/doi.org\/10.3389\/FONC.2022.1044830","DOI":"10.3389\/FONC.2022.1044830"},{"key":"5485_CR2","doi-asserted-by":"publisher","unstructured":"Shalata AT, Shehata M, Van Bogaert E, Ali KM, Alksas A, Mahmoud A, El-Gendy EM, Mohamed MA, Giridharan GA, Contractor S et al (2022) Predicting recurrence of non-muscle-invasive bladder Cancer: current techniques and future trends. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/CANCERS14205019","DOI":"10.3390\/CANCERS14205019"},{"key":"5485_CR3","first-page":"1","volume":"31","author":"European Assocition of Urology","year":"2023","unstructured":"European Assocition of Urology (2023) Non-muscle-invasive bladder Cancer (TaT1 and CIS) EAU guidelines. Eur Urol 31:1\u201348","journal-title":"Eur Urol"},{"key":"5485_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","volume":"66","author":"RS Svatek","year":"2014","unstructured":"Svatek RS, Hollenbeck BK, Holm\u00e4ng S, Lee R, Kim SP, Stenzl A, Lotan Y (2014) The economics of bladder Cancer: costs and considerations of caring for this disease. Eur Urol 66:253\u2013262. https:\/\/doi.org\/10.1016\/j.eururo.2014.01.006","journal-title":"Eur Urol"},{"key":"5485_CR5","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-14-0029","volume":"23","author":"LM Chen","year":"2014","unstructured":"Chen LM, Chang M, Dai Y, Chai KX, Dyrskj\u00f8t L, Sanchez-Carbayo M, Szarvas T, Zwarthoff EC, Lokeshwar V, Jeronimo C et al (2014) External validation of a multiplex urinary protein panel for the detection of bladder Cancer in a Multicenter Cohort. Cancer Epidemiol Biomarkers Prev 23:1804\u20131812. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0029","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5485_CR6","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.urolonc.2019.05.019","volume":"37","author":"T Iwata","year":"2019","unstructured":"Iwata T, Kimura S, Abufaraj M, Janisch F, Parizi MK, Haitel A, Rink M, Roupr\u00eat M, Fajkovic H, Seebacher V et al (2019) Prognostic role of the urokinase plasminogen activator (UPA) system in patients with nonmuscle invasive bladder Cancer. Urol Oncol Semin Orig Investig 37:774\u2013783. https:\/\/doi.org\/10.1016\/j.urolonc.2019.05.019","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"5485_CR7","doi-asserted-by":"publisher","unstructured":"Lema\u00eetre G, Nogueira FK (2017) A Imbalanced-Learn. Imbalanced-Learn Lema\u00eetreGuillaume;NFKA (2017) J Mach Learn Res. https:\/\/doi.org\/10.5555\/3122009.3122026","DOI":"10.5555\/3122009.3122026"},{"key":"5485_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DWW, Kurth K (2006) Predicting recurrence and progression in individual patients with Stage Ta T1 bladder Cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013465 discussion 475-7. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031","journal-title":"Eur Urol"},{"key":"5485_CR9","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/J.JURO.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pi\u00f1eiro L, Gonzalez M, Portillo J, Ojea A, Pertusa C, Rodriguez-Molina J et al (2009) Predicting Nonmuscle invasive bladder Cancer recurrence and progression in patients treated with Bacillus Calmette-Guerin: the CUETO Scoring Model. J Urol 182:2195\u20132203. https:\/\/doi.org\/10.1016\/J.JURO.2009.07.016","journal-title":"J Urol"},{"key":"5485_CR10","first-page":"2381","volume":"33","author":"PK Kopparapu","year":"2013","unstructured":"Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas LJ, Mongan NP, Persson JL (2013) Expression of VEGF and its receptors VEGFR1\/VEGFR2 is Associated with invasiveness of bladder Cancer. Anticancer Res 33:2381\u20132390","journal-title":"Anticancer Res"},{"key":"5485_CR11","doi-asserted-by":"publisher","unstructured":"Reis ST, Leite KRM, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP, Srougi M et al (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder Cancer. BMC Urol 12. https:\/\/doi.org\/10.1186\/1471-2490-12-18","DOI":"10.1186\/1471-2490-12-18"},{"key":"5485_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/J.1464-410X.2012.11653.X","volume":"112","author":"M Lind\u00e9n","year":"2013","unstructured":"Lind\u00e9n M, Segersten U, Runeson M, Wester K, Busch C, Pettersson U, Lind SB, Malmstr\u00f6m PU (2013) Tumour expression of bladder Cancer-Associated urinary proteins. BJU Int 112:407\u2013415. https:\/\/doi.org\/10.1111\/J.1464-410X.2012.11653.X","journal-title":"BJU Int"},{"key":"5485_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/1541-7786.MCR-13-0543","volume":"12","author":"EG Giacoia","year":"2014","unstructured":"Giacoia EG, Miyake M, Lawton A, Goodison S, Rosser CJ (2014) PAI-1 leads to G1-Phase cell-cycle progression through cyclin D3\/Cdk4\/6 Upregulation. Mol Cancer Res 12:322\u2013334. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0543","journal-title":"Mol Cancer Res"},{"key":"5485_CR14","doi-asserted-by":"publisher","first-page":"e47469","DOI":"10.1371\/journal.pone.0047469","volume":"7","author":"S Goodison","year":"2012","unstructured":"Goodison S, Chang M, Dai Y, Urquidi V, Rosser CJ (2012) A Multi-analyte assay for the non-invasive detection of bladder Cancer. PLoS ONE 7:e47469. https:\/\/doi.org\/10.1371\/journal.pone.0047469","journal-title":"PLoS ONE"},{"key":"5485_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/1354750X.2016.1276628","volume":"22","author":"S Gogalic","year":"2017","unstructured":"Gogalic S, Sauer U, Doppler S, Heinzel A, Perco P, Lukas A, Simpson G, Pandha H, Horvath A, Preininger C (2017) Validation of a Protein Panel for the Noninvasive detection of recurrent non-muscle invasive bladder Cancer. Biomarkers 22:674\u2013681. https:\/\/doi.org\/10.1080\/1354750X.2016.1276628","journal-title":"Biomarkers"},{"key":"5485_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0022-5347(01)61772-5","volume":"161","author":"JP Crew","year":"1999","unstructured":"Crew JP, O\u2019Brien T, Bicknell R, Fuggle S, Cranston D, Harris AL (1999) Urinary vascular endothelial growth factor and its correlation with bladder Cancer Recurrence Rates. J Urol 161:799\u2013804. https:\/\/doi.org\/10.1016\/S0022-5347(01)61772-5","journal-title":"J Urol"},{"key":"5485_CR17","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.euf.2021.08.006","volume":"8","author":"K Mori","year":"2022","unstructured":"Mori K, Schuettfort VM, Katayama S, Laukhtina E, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann NC, Rajwa P et al (2022) The value of preoperative plasma VEGF levels in Urothelial Carcinoma of the bladder treated with Radical Cystectomy. Eur Urol Focus 8:972\u2013979. https:\/\/doi.org\/10.1016\/j.euf.2021.08.006","journal-title":"Eur Urol Focus"},{"key":"5485_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00345-020-03188-x","volume":"39","author":"V Srougi","year":"2021","unstructured":"Srougi V, Reis ST, Viana N, Gallucci FP, Leite KR, Srougi M, Nahas WC (2021) Prospective evaluation of a urinary biomarker panel to detect and predict recurrence of non-muscle-invasive bladder Cancer. World J Urol 39:453\u2013459. https:\/\/doi.org\/10.1007\/s00345-020-03188-x","journal-title":"World J Urol"},{"key":"5485_CR19","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3816\/CGC.2009.n.016","volume":"7","author":"L Sagnak","year":"2009","unstructured":"Sagnak L, Ersoy H, Ozok U, Senturk B, Ercil H, Bahar G, Ozturk E (2009) Predictive value of urinary Interleukin-8 Cutoff Point for recurrences after Transurethral resection plus induction Bacillus Calmette-Gu\u00e9rin treatment in non-muscle-invasive bladder tumors. Clin Genitourin Cancer 7:E16\u2013E23. https:\/\/doi.org\/10.3816\/CGC.2009.n.016","journal-title":"Clin Genitourin Cancer"},{"key":"5485_CR20","doi-asserted-by":"publisher","first-page":"e1265719","DOI":"10.1080\/2162402X.2016.1265719","volume":"6","author":"K Qu","year":"2017","unstructured":"Qu K, Gu J, Ye Y, Williams SB, Dinney CP, Wu X, Kamat A (2017) High baseline levels of Interleukin-8 in leukocytes and urine predict Tumor recurrence in non-muscle invasive bladder Cancer patients receiving Bacillus Calmette\u2013Guerin Therapy: a long-term survival analysis. Oncoimmunology 6:e1265719. https:\/\/doi.org\/10.1080\/2162402X.2016.1265719","journal-title":"Oncoimmunology"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05485-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05485-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05485-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:02:15Z","timestamp":1767996135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05485-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5485"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05485-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval of the Bioethics Committee of the Wroclaw Medical University was obtained (approval number: KB \u2212\u2009692\/2019; Ethical Statement Date: 22nd October 2019, Wroc\u0142aw). Every study participant has signed the informed consent form (ICF).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}